Leptin and the clinical cardiovascular risk

International Journal of Cardiology

Volumn 140, Issue 3, 2010, Pages 266-271

  Singh, Mukesh ^a   Bedi, Updesh S ^a   Singh, Param P ^a   Arora, Rohit ^a   Khosla, Sandeep ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cardiovascular disease; Diabetes; Hypertension; Leptin; Obesity

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; LEPTIN RECEPTOR; NICOTINE;

ACUTE HEART INFARCTION; ARTERIAL WALL THICKNESS; ATHEROGENESIS; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DYSLIPIDEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID METABOLISM; NONHUMAN; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SMOKING; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HOMEOSTASIS; HUMANS; HYPERTENSION; LEPTIN; OBESITY; RISK FACTORS;

EID: 77954889746     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.07.019     Document Type: Review

References (105)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among adults, 1999-2000. JAMA 2002;288:1723-7.
2. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity associated cardiovascular and renal disease. Am J Sci 2002;324:127-37.
3. Kumanyika S. Obesity in black women. Epidemiol Rev 1987;9:31-50.
4. Garrison RJ, Kannel WB, Stokes 3rd J, Castelli WP. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 1987;16:235-51.
5. Bradley RL, Cleveland KA, Cheatham B. The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. Recent Prog Horm Res 2001;56:329-58.
6. Guha PK, Villarreal D, Reams GP, Freeman RH. Role of leptin in the regulation of body fluid volume and pressures. Am J Ther 2003;10:211-8.
7. Misra A, Garg A. Leptin: its receptor and obesity. J Invest Med 1996;44:540-8.
8. Lonnqvist F. The obese (ob) gene and its product leptin: a new route towards obesity treatment in man? J Med 1996;89:327-32.
9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372: 425-32.
10. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:1407-33.
11. Seufert J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 2004;53(suppl 1):S152-8.
12. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-8.
13. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997;46: 2040-3.
14. Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive and obese rats. Am J Physiol 1998;275:R2056-60.
15. Tartaglia LA. The leptin receptor. J Biol Chem 1997;272:6093-6.
16. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491-5.
17. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-6.
18. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001;47:141-50.
19. Parhami F, Tintut Y, Ballard A, et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001;88:954-60.
20. Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276:25096-100.
21. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
22. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002;20:1245-50.
23. Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001;74:295-301.
24. Flanagan DE, Vaile JC, Petley GW, et al. Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept 2007;140:37-42.
25. Menendez C, Baldelli R, Lage M, et al. The in vitro secretion of human leptin is gender-dependent but independent of the body mass index of the donors. Eur J Endocrinol 2000;143:711-4.
26. Cooke JP, Oka RK. Does leptin cause vascular disease? Circulation 2002;106: 1904-5.
27. Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002;26 (Suppl 2):S28-38.
28. Beltowski J, Wojcicka G, Gorny D, Marciniak A. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat - impaired effect in dietary-induced obesity. Med Sci Monit 2002;8:BR221-9.
29. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001;8:1533-40.
30. Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002;287: 1706-9.
31. Chu NF, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord 2000;24:1085-92.
32. Chaldakov GN, Fiore M, Stankulov IS, et al. NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch Physiol Biochem 2001;109:357-60.
33. Singhal A, Farooqi IS, Cole TJ, et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002;106:1919-24.
34. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004;181:1-10.
35. Soderberg S, Ahren B, Stegmayr B, et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999;30:328-37.
36. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 1998;19:1547-51.
37. Schulze PC, Kratzsch J, Linke A, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003;5:33-40.
38. Soderberg S, Ahren B, Jansson JH, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999;246:409-18.
39. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001;104:3052-6.
40. Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999;34:1047-52.
41. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the US population. Am J Cardiol July 15 2007;100(2):234-9.
42. Wolf G,Hamann A,Han DC, et al. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Intl 1999;56:860-72.
43. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006;189:47-60.
44. CorreiaML, HaynesWG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004;13:215-23.
45. Werner N, Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol 2004;24:7-9.
46. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006;24:789-801.
47. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002;39:496-501.
48. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358:1400-4.
49. Cohn J. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001;14(8 Pt 2):258S-63S.
50. Takekoshi K, Motooka M, Isobe K, et al. Leptin directly stimulates catecholamine secretion and synthesis in cultured porcine adrenal medullary chromaffin cells. Biochem Biophys Res Commun 1999;261:426-31.
51. Reseland JE, Mundal HH, Hollung K, et al. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins Leukot Essent Fat Acids 2005;73:43-9.
52. Li MD, Kane JK. Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat. Brain Res 2003;991:222-31.
53. Wallerstedt SM, Eriksson AL, Niklason A, Ohlsson C, Hedner T. Serum leptin and myocardial infarction in hypertension. Blood Press 2004;13:243-6.
54. Soderberg S, Stegmayr B, Stenlund H, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 2004;256:128-36.
55. Makris TK, Hatzizacharias AN, Krespi PG, et al. Markers of risk in young offspring with paternal history of myocardial infarction. Int J Cardiol 2003;89:287-93.
56. Wallander M, Soderberg S, Norhammer A. Leptin-a predictor of abnormal glucose tolerance and prognosis in patientswithmyocardial infarction and without previously known Type 2 diabetes. Diabet Med 2008;25(8):949-55.
57. Piatti P, DiMario C,Monti LD, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003;108:2074-81.
58. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patientswith established coronary atherosclerosis. JAmColl CardiolNov 2 2004;44(9):1819-24.
59. Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F, et al. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Prac Cardiovasc Med 2008;5:418-25.
60. Piemonti L, CaloriG,MercalliA, et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose intolerant women: impact on cardiovascular mortality. Diabetes Care 2003;26:2883-9.
61. Winnicki M, Somers VK, Accurso V, et al. Fish-rich diet, leptin, and body mass. Circulation 2002;106:289-91.
62. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA 2002;288:3130-6.
63. Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001;25:805-10.
64. van den BeldAW, BotsML, Janssen JA, PolsHA, Lamberts SW,GrobbeeDE. Endogenous hormones and carotid atherosclerosis inelderlymen.AmJ Epidemiol 2003;157:25-31.
65. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 2004;112:378-82.
66. McNeelyMJ, Boyko EJ,Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999;22:65-70.
67. Söderberg S, Zimmet P, Tuomilehto J, et al. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 2007;31:1126-33.
68. Wannamethee SG, Lowe GD, Rumley A, Cherry L,Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007;30:1200-5.
69. Ruige JB, Dekker JM, Blum WF, et al. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study: the Hoorn Study. Diabetes Care 1999;22:1097-104.
70. Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Leptin acts in the central nervous system to producedose-dependent changes in arterial pressure.Hypertension 2001;37:936-42.
71. Beltowski J, Wojcicka G, Marciniak A, Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 2004;74:2987-3000.
72. Correia ML, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 2001;38:384-8.
73. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31:409-14.
74. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000;105:1243-52.
75. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R. Identification and expression of cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
76. Mark AL, Shaffer RA, CorreiaML. Contrasting blood pressure effects of obesity in leptindeficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999;17:1949-53.
77. Agata J, Masuda A, Takada M, et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997;10:1171-4.
78. Gannagé-Yared MH, Azar RR, Amm-Azar M, et al. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients. Metabolism 2005;54:947-51.
79. Kunz I, Schorr U, Klaus S, et al. Resting metabolic rate and substrate use in obesity hypertension. Hypertension 2000;36:26-32.
80. Golan E, Tal B, Dror Y, et al. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity related hypertension. Isr Med Assoc J 2002;4:426-30.
81. Itoh K, Imai K, Masuda T, et al. Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 2002;25:881-6.
82. Al-Hazimi AM, Syiamic AY. Relationship between plasma angiotensin II, leptin and arterial blood pressure. Saudi Med J 2004;25:1193- 8.
83. Canatan H, Bakan I, Akbulut M, et al. Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects. Endocr Res 2004;30:95-105.
84. Schutte R, Huisman HW, Schutte AE, et al. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens 2005;19:535-41.
85. Uckaya G, Ozata M, Sonmez A, et al. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension. Horm Metab Res 1999;31:435-8.
86. Adamczak M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinaemia in patients with essential hypertension. J Hum Hypertens 2000;14:503-9.
87. Takizawa H, Ura N, Saitoh S, et al. Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens 2001;23: 357-68.
88. Barba G, Russo O, Siani A, et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003;11:160-6.
89. Canatan H, Bakan I, Akbulut M, et al. Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biol Trace Elem Res 2004;100:117-23.
90. Anato V, Garmendia JV, Bianco NE, et al. Serum leptin levels in different types of hypertension during pregnancy. Res Commun Mol Pathol Pharmacol 2000;108: 147-53.
91. Vitoratos N, Chrystodoulacos G, Kouskouni E, et al. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol 2001;96:59-62.
92. Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 2003;52: 2121-8.
93. O'Rourke L, Yeaman SJ, Shepherd PR. Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signaling pathways. Diabetes 2001;50:955-61.
94. O'Rourke L, Gronning LM, Yeaman SJ, Shepherd PR. Glucose dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 2002;277:42557-62.
95. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997;132:237-43.
96. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7α-hydroxylase (Cyp7a1) in leptin deficient (ob/ob) mice. J Biol Chem 2003;278: 43224-8.
97. Ünal M, Öztürk L. The effect of body mass index on the severity of obstructive sleep apnea. In: Ferrera, LA, editor. Body mass index and health. New York: Nova Science Publishers; 2005. p. 81-96.
98. Dancey DR, Hanly PJ, Soong C, Lee B, Shepard J, Hoffstein V. Gender differences in sleep apnea: the role of neck circumference. Chest 2003;123:1544-50.
99. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-8.
100. Öztürk L, Ünal M, Tamer L, Çelikoǧlu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003;129:538-40.
101. Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008;186:209-17.
102. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999;100:706-12.
103. Saarelainen S, Lahtela J, Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997;6:146-7.
104. Cuhadaroǧlu C, Utkusavaş A, Oztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung Mar-Apr 2009;187(2):75-81.
105. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.